Glenmark Pharma Shares Soar 4% as Blood Cancer Drug Indicate Good Signs
Shares of Glenmark Pharmaceuticals Ltd jumped more than 4% on 10 December following the company’s announcement that the initial clinical data for its blood cancer...
Tag : cancer drug
54th GST Council Meeting’s Outcomes, Rate Cuts
The Monday meeting of the GST Council announced significant tax reductions to make essential goods and services more affordable. These include lowering the GST on...
DCGI Approves AstraZeneca’s Drug for Treatment of High-risk Early Breast Cancer
On Friday, the Drugs Controller General of India (DCGI) has given its market approval to the drug Lynparza (Olaparib) as a monotherapy for the adjuvant...
Aurobindo Pharma Acquires 51% Stake in GLS Pharma
Aurobindo Pharma has completed the acquisition of GLS Pharma Limited with a 51 per cent stake. In June, the Board of Aurobindo Pharma approved the...
Alembic’s associate company receives USFDA approval for cancer drug
Alembic Pharmaceuticals associate company Rhizen Pharmaceuticals has received approval from USFDA for cancer drug. According to a BSE release, “Rhizen Pharmaceuticals S.A. today announced that...
Biocon launches cancer drug KRABEVA, in India
Biocon has launched KRABEVA, a biosimilar Bevacizumab, in India. It is used for treating patients with metastatic colorectal cancer and other types of lung, kidney, cervical, ovarian...
Lupin receives USFDA approval to market cancer drug
Lupin Ltd has got a final approval from the USFDA for marketing sodium, potassium sulfate, magnesium sulfate oral solution that are used in treatment of...
Natco Pharma’s partner MylanInc has received USFDA’s approval for cancer drug
Natco Pharma has said that its marketing partner Mylan Inc has got tentative approval from the US health regulator for selling generic Sorafenib tablets that...
